Previous 10 | Next 10 |
Inari Medical (NASDAQ:NARI) said the first patient was enrolled in a trial called PEERLESS, comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus catheter-directed thrombolysis (CDT). Pulmonary embolism is a bloc...
IRVINE, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial (“RCT”) comparing the outcomes of patients with interme...
IRVINE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that it will release its fourth ...
IRVINE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quar...
IRVINE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will pr...
We are all ready to move past COVID and return to normality. Nonetheless, there's a new variant in town called Omicron, and we don't know yet how serious or not-serious this variant will be. The last highly contagious variant was Delta, and there were several other not-so-serious variants d...
Image source: The Motley Fool. Inari Medical, Inc. (NASDAQ: NARI) Q3 2021 Earnings Call Nov 09, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inari Medical, Inc. (NARI) Q3 2021 Earnings Call Transcript
Gainers: PubMatic (NASDAQ:PUBM) +23%. Veritone (NASDAQ:VERI) +16%. Synalloy Corporation (NASDAQ:SYNL) +15%. Avid Technology (NASDAQ:AVID) +14%. Inari Medical (NASDAQ:NARI) +13%. Losers: Poshmark (NASDAQ:POSH) -27%. Purple Innovation (NASDAQ:PRPL) ...
Inari Medical (NASDAQ:NARI): Q3 GAAP EPS of -$0.06 beats by $0.01. Revenue of $72.91M (+88.3% Y/Y) beats by $9.88M. Press Release For further details see: Inari Medical EPS beats by $0.01, beats on revenue
IRVINE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported financial results for its third q...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...
2024-06-01 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...